Former Aegerion Execs Say FDA Approval Negates FCA Case
Former executives at Aegerion Pharmaceuticals Inc. argued Tuesday that a False Claims Act case against them ignores a federal regulatory program that gave marketers and doctors explicit permission to recommend an...To view the full article, register now.
Already a subscriber? Click here to view full article